We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.
- Authors
Acevedo, E; Castañeda, O; Ugaz, M; Beaulieu, A D; Pons-Estel, B; Caeiro, F; Casas, N; Garza-Elizondo, M; Irazoque, F; Hinojosa, W; Gutierrez-Ureña, S; Vandormael, K; Rodgers, D B; Laurenzi, M
- Abstract
To compare the incidence of selected spontaneously reported adverse events (AEs) in patients with osteoarthritis (OA) treated with rofecoxib (VIOXX, 12.5 mg qd) or Arthrotec (diclofenac 50 mg/misoprostol 200 mcg bid).
- Publication
Scandinavian journal of rheumatology, 2001, Vol 30, Issue 1, p19
- ISSN
0300-9742
- Publication type
Journal Article
- DOI
10.1080/030097401750065274